Drag a card by its title · ⚙ to size, swap or remove

The company

Janux Therapeutics, Inc.

JANX · Nasdaq

Health CareBiotechnologyLeading

JANX stood above a rising 150-day average in 13 of the last 52 weekly readings, including each of the last 11 weeks. It is 6.9% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 11 in a row
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $1.4M
Officials’ trades on record: 0
Institutions holding: 182 (+7)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months11

Buyers · sellers0 · 7

Who	Did	Shares	Traded
Janeen Noel DoyleChief Corp. & Bus. Dev. Ofcr	sold	4,059at $14.03	2 Jun 2026filed 4 Jun 2026
Maria DobekVice President, Accounting	sold	2,038at $14.17	11 May 2026filed 13 May 2026
David Alan CampbellPresident and CEO	sold	8,072at $13.73	2 Jan 2026filed 2 Jan 2026
Andrew Hollman MeyerChief Business Officer	sold	1,879at $13.73	2 Jan 2026filed 2 Jan 2026
Charles M. WinterChief Technical Officer	sold	2,401at $13.73	2 Jan 2026filed 2 Jan 2026
Thomas DiraimondoChief Scientific Officer	sold	2,505at $13.73	2 Jan 2026filed 2 Jan 2026
Maria DobekVice President, Accounting	sold	1,462at $13.73	2 Jan 2026filed 2 Jan 2026
Zachariah McIverChief Medical Officer	sold	2,714at $13.73	2 Jan 2026filed 2 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders182+7 on the quarter

New · exited36 · 30

Reported value$923.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	11,189,693$171.9M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	6,134,667$94.2M	+701,434+12.9%
Prosight Management, LPadded · filed 14 Aug 2026	3,804,481$58.4M	+254,481+7.2%
STATE STREET CORPadded · filed 7 Aug 2026	3,004,899$46.2M	+540,882+22.0%
FMR LLCreduced · filed 13 Aug 2026	2,412,825$37.1M	-122,899−4.8%
FEDERATED HERMES, INC.added · filed 12 Aug 2026	2,352,927$36.1M	+2,298,727+4241.2%
Point72 Asset Management, L.P.added · filed 14 Aug 2026	1,993,837$30.6M	+837,697+72.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,857,351$28.5M	+45,986+2.5%
TCG Crossover Management, LLCunchanged · filed 14 Aug 2026	1,789,617$27.5M	00.0%
Alyeska Investment Group, L.P.added · filed 14 Aug 2026	1,647,140$25.3M	+46,051+2.9%